Records containing: Seborrheic Dermatitis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-24Development of a Sample Collection Protocol and a Metabolomics/Lipidomics Analytical Strategy for Investigating Sebum and Its Clinical Applications
-
CLINICAL_TRIALS study record update · 2026-04-23A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase Ⅰb Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of Different Concentrations of ZYG24002 Lotion in Adult Patients With Mild to Moderate Seborrheic Dermatitis
-
CLINICAL_TRIALS study record update · 2026-02-24A Multi-Reader Multi-Case (MRMC) Study for Assessing the Impact of Legit.Health Plus on the Clinical Assessment of Generalized Pustular Psoriasis and Other Skin Conditions by Healthcare Professionals.
-
CLINICAL_TRIALS study record update · 2026-02-05A Randomized, Double-Blind, Placebo-Controlled Clinical Study to Evaluate the Safety and Efficacy of Scalp Cream for Symptom Relief and Microbiome Balance in Mild-moderate Seborrheic Dermatitis Patients.
-
CLINICAL_TRIALS study record update · 2025-12-22Phenotypic and Functional Profile of Peripheral Blood Lymphomonocytes in Seborrheic Dermatitis.
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-12-17Cleansing Device for the Treatment of Scalp and Hair Conditions
-
CLINICAL_TRIALS study record update · 2025-05-06Characterizing the Molecular Cutaneous Phenotype of Seborrheic Dermatitis and Treatment Response to Ruxolitinib 1.5% Cream
-
CLINICAL_TRIALS study record update · 2025-04-24PDE4 Inhibition in the Treatment of Seborrheic Dermatitis and Papulopustular Rosacea With PF-07038124
-
CLINICAL_TRIALS study record update · 2024-08-27The Use of Image-Based Computer Gradings in the Analysis of Acne, Rosacea, Melasma, and Seborrheic Dermatitis
-
CLINICAL_TRIALS study record update · 2024-06-11A Phase 2, Multicenter, Open-Label Study of the Long-Term Safety of ARQ-154 Foam 0.3% in Subjects With Seborrheic Dermatitis
-
CLINICAL_TRIALS study record update · 2024-06-07Using the SpiderMass(TM) for in Vivo and Real Time Mass Spectrometry Analysis of Subject's Epidermis Suffering From Chronic Inflammatory Dermatosis Compared to Control Groups
-
CLINICAL_TRIALS study record update · 2024-05-20Petrolatum's Effect on Initial Symptoms of Nonscalp Seborrheic Dermatitis and Preventing Exacerbation
-
CLINICAL_TRIALS study record update · 2024-03-12A Phase 3, 8-Week, Parallel Group, Double Blind, Vehicle-Controlled Study of the Safety and Efficacy of ARQ-154 Foam 0.3% Administered QD in Subjects With Seborrheic Dermatitis
-
CLINICAL_TRIALS study record update · 2023-07-03A Phase 2b, 8-Week, Parallel Group, Double Blind, Vehicle-Controlled Study of the Safety and Efficacy of ARQ-154 Foam 0.3% Administered QD in Subjects With Seborrheic Dermatitis
-
CLINICAL_TRIALS study record update · 2022-04-13Retrospective Study to Evaluate the Safety of Sebryl® and / or Sebryl Plus® in the Treatment of Seborrheic Dermatitis and Psoriasis of the Scalp in Routine Medical Practice.
-
CLINICAL_TRIALS study record update · 2022-03-14A 4 Week Randomized Double-blind Parallel Group Active Comparator Controlled Study of Elidel (Pimecrolimus) for the Treatment of Seborrheic Dermatitis
-
CLINICAL_TRIALS study record update · 2021-10-29A Proof of Concept Clinical Trial Evaluating the Safety and Efficacy of Eucrisa (Crisaborole) in Patients With Seborrheic Dermatitis
-
CLINICAL_TRIALS study record update · 2021-08-11Pilot Study for the Use of Photodynamic Therapy in the Treatment of Seborrheic Dermatitis
-
CLINICAL_TRIALS study record update · 2020-09-10Comparison of Scalp Microbiota of the Patients With Psoriasis Vulgaris and Seborrheic Dermatitis
-
CLINICAL_TRIALS study record update · 2019-05-01A Phase 2, Randomized, Vehicle and Ketoconazole-Controlled, Evaluator-Blinded, Study to Explore the Efficacy, Pharmacodynamics and Safety of Omiganan 1.75% Topical Gel BID in Patients With Mild to Moderate Facial Seborrheic Dermatitis
-
CLINICAL_TRIALS study record update · 2017-11-06Seborrheic Dermatitis of the Scalp in Populations Practicing Less Frequent Hair Washing: Ketoconazole 2% Foam Versus Ketoconazole 2% Shampoo
-
CLINICAL_TRIALS study record update · 2017-03-27Neurobiology of the Scalp in Seborrheic Dermatitis
-
CLINICAL_TRIALS study record update · 2016-04-25A Randomized, Double-blind, Single Center, Investigator-initiated Clinical Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Subjects With Mild to Moderate Seborrheic Dermatitis of the Face
-
CLINICAL_TRIALS study record update · 2016-01-14Safety and Efficacy of SEBORRHEAMEDIS Face Cream in Patients With Seborrheic Dermatitis
-
CLINICAL_TRIALS study record update · 2013-01-09A Parallel-group, Vehicle-controlled, Randomized, Double-blind Study of the Efficacy and Safety of Product 49778 and Product 10156 in Subjects With Seborrheic Dermatitis